Metraipolis › archive › dc_d652ee7e7964
Case Report: Management of a BCR-ABL1-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors — Europe PMC PMID:41158453
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41158453
- DOI
- 10.3389/fmed.2025.1693688
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:04:14.156Z
- SHA-256 of the archived text
dc0ee429b0f81442ce4696538c32cf27d38e871b51a4556d16a35a0eb9c69360- Stable URL of this page
https://metraipolis.com/documento/dc_d652ee7e7964
How to cite
Case Report: Management of a BCR-ABL1-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors — Europe PMC PMID:41158453 — Europe PMC (en), https://europepmc.org/article/MED/41158453 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d652ee7e7964 (Metraipolis archive dc_d652ee7e7964, sha256 dc0ee429b0f81442ce4696538c32cf27d38e871b51a4556d16a35a0eb9c69360)
BibTeX
@misc{dcd652ee7e7964,
title = {Case Report: Management of a BCR-ABL1-positive high-risk rhabdomyosarcoma patient using tyrosine kinase inhibitors — Europe PMC PMID:41158453},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41158453},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d652ee7e7964; sha256 dc0ee429b0f81442ce4696538c32cf27d38e871b51a4556d16a35a0eb9c69360},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41158453. Agents can read the archived copy with the MCP tool read_document.